# Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699

> **NCT03606408** · PHASE2 · COMPLETED · sponsor: **RECORDATI GROUP** · enrollment: 127 (actual)

## Conditions studied

- Cushing's Syndrome

## Interventions

- **DRUG:** osilodrostat

## Key facts

- **NCT ID:** NCT03606408
- **Lead sponsor:** RECORDATI GROUP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-05
- **Primary completion:** 2023-11-16
- **Final completion:** 2023-11-16
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03606408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03606408, "Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03606408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*